12 cases of brain disease after vaccines

Oct 24, 2006

The U.S. Food and Drug Administration said 12 cases of a neurological disorder have been reported following the application of a meningococcal vaccine.

The FDA said the 12 cases of Guillain-Barre Syndrome have been reported after administering of the vaccines, which are manufactured by French company Sanofi Pasteur, since October 2005, The Wall Street Journal reported Tuesday.

However, the FDA said sufficient evidence was not available to tie the vaccine to the disease and patients should continue to use it if instructed by their doctors.

The vaccines are used to prevent meningococcal disease, which causes bacterial meningitis -- an infection that attacks the lining of the brain and spinal cord. The disease affects about 1-in-100,000 young people every year.

Copyright 2006 by United Press International

Explore further: Harmful drinkers would be affected 200 times more than low risk drinkers with an MUP

add to favorites email to friend print save as pdf

Related Stories

The problem of false balance when reporting on science

Jul 17, 2014

How do you know the people billed as science experts that you see, hear and read about in the media are really all that credible? Or have they been included just to create a perception of balance in the coverage ...

New UN force on climate impacts on health

Jul 08, 2014

Two UN agencies on Tuesday announced they were setting up a joint office to help fight the threat to health from climate change and extreme weather.

Recommended for you

Research looks to combat US Latina immigrant obesity

5 hours ago

According to the U.S. Census Bureau, Latinos are the largest minority group in the United States, comprising 16.7% of the population. Approximately one-third of Latinos are obese and are 1.2 times as likely to be obese compared ...

User comments : 0